Table 1. Correlation of clinicopathological characteristics and serum miR-101 expression in the cervical cancer patients.
| Variables | No. of patients (n=182) | MiR-101 expression | p-value | ||
|---|---|---|---|---|---|
| Low | High | ||||
| Age (yr) | 0.325 | ||||
| ≤50 | 134 | 56 (41.8) | 78 (58.2) | ||
| >50 | 48 | 24 (50.0) | 24 (50.0) | ||
| FIGO stage | 0.003 | ||||
| IB1–IIA1 | 153 | 60 (39.2) | 93 (60.8) | ||
| IIA2–IIIB | 29 | 20 (69.0) | 9 (31.0) | ||
| Tumor size (cm) | 0.123 | ||||
| ≤4 | 150 | 62 (41.3) | 88 (58.7) | ||
| >4 | 32 | 18 (56.3) | 14 (43.7) | ||
| Histology | 0.972 | ||||
| Squamous | 139 | 61 (43.9) | 78 (56.1) | ||
| Adenocarcinoma | 43 | 19 (44.2) | 24 (55.8) | ||
| Differentiation | 0.078 | ||||
| Well-moderate | 161 | 67 (41.6) | 94 (58.4) | ||
| Poor | 21 | 13 (61.9) | 8 (38.1) | ||
| Lymph nodes metastasis | 0.001 | ||||
| No | 145 | 55 (37.9) | 90 (62.1) | ||
| Yes | 37 | 25 (67.6) | 12 (32.4) | ||
| SCC-Ag (ng/L) | 0.007 | ||||
| ≤4 | 132 | 50 (37.9) | 82 (62.1) | ||
| >4 | 50 | 30 (60.0) | 20 (40.0) | ||
Values are presented as number (%).
FIGO, International Federation of Gynecology and Obstetrics; SCC-Ag, squamous cell carcinoma antigen.